Analyst Ratings for Insulet
Over the past 3 months, 6 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Jefferies Initiates Coverage On Insulet with Hold Rating, Announces Price Target of $260
Jefferies analyst Matthew Taylor initiates coverage on Insulet (NASDAQ:PODD) with a Hold rating and announces Price Target of $260.
$1000 Invested In Insulet 5 Years Ago Would Be Worth This Much Today
Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.25% on an annualized basis producing an average annual return of 35.42%. Currently, Insulet has a market capitalization of $18.24 billion.
Recap Of Monday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery…
FDA Clears Insulet’s Omnipod 5 Automated Insulin Delivery System For Preschool Children
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D).
Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $290
Canaccord Genuity analyst Kyle Rose maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $250 to $290.
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
Insulet Corporation (NASDAQ:PODD) posted a Q2 net loss of $(35) million, or an EPS loss of $(0.50) compared to $(0.37)…
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Insulet Announces Full Market Release of Omnipod 5 Automated Insulin Delivery System
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its Omnipod® 5 Automated Insulin Delivery